Curanex Pharmaceuticals CURX Cash Flow Statement (2024-2026)

NASDAQ CURX
$4.97 -0.06 (-1.29%)
As of: Sep 29, 2026 · 3:50 PM EDT
Reported Financials

Curanex Pharmaceuticals Quarterly Cash Flow Statement

Periods 6 quarters
Latest Jun 2026

Curanex Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2024 Dec2024 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income -0.09M-0.15M-0.06M-0.96M-3.09M-3.33M
Cash from OperationsCash from Ops. -0.13M-0.10M-9.19M-0.86M
Change in Working Capital
Change in Account PayablesChange Payables 0.11M-0.11M
Change in Accured ExpensesChange Accured Exp. 0.00M0.01M0.01M0.00M
Other Working Capital ChangesOther WC Changes 0.05M0.03M8.36M-2.33M
Financing Activities
Cash from Financing ActivitiesCash from Financing 14.91M
Additional items
Change in Cash -0.13M-0.10M5.72M-0.86M
Free Cash FlowFCF -0.13M-0.10M-9.19M-0.86M
Net Cash FlowNCF -0.13M-0.10M5.72M-0.86M

Curanex Pharmaceuticals Cash Flow Statement API

Pull Curanex Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CURX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY